This medicine is an oral medication used primarily for the management of type 2 diabetes mellitus.
It belongs to a class of drugs known as SGLT2 inhibitors, which work by preventing the reabsorption of glucose in the kidneys, leading to increased glucose excretion in urine.

Benefits:
-Helps lower blood sugar levels in adults with type 2 diabetes.
-May aid in weight loss due to the caloric loss from glucose excretion.
-Can reduce the risk of cardiovascular events in patients with established heart disease.
-May have beneficial effects on kidney function and slow the progression of diabetic kidney disease.

Precautions:
-Not recommended for individuals with severe renal impairment or end-stage renal disease.
-Caution is advised for patients with a history of urinary tract infections (UTIs) or genital infections, as these may be more common with SGLT2 inhibitors.
-Patients should be monitored for signs of dehydration, especially if they are on diuretics or have low blood pressure.
-Use during pregnancy and breastfeeding should be discussed with a healthcare provider.

Side Effects:
-Common side effects include urinary tract infections, genital mycotic infections, and increased urination.
-Other potential side effects may include dizziness, fatigue, and nausea.
-Rare but serious side effects can include ketoacidosis, acute kidney injury, and hypersensitivity reactions.

Main Ingredients and Their Benefits:
Dapagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor used primarily for the management of type 2 diabetes mellitus. It works by preventing glucose reabsorption in the kidneys, leading to increased glucose excretion through urine leading to effectively lower blood sugar levels by promoting the excretion of excess glucose, which helps patients achieve better glycemic control and reduces HbA1c levels.